Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss...
What You Need to Know About New Weight Loss Drugs
2024年10月21日 · Are Ozempic, Wegovy and other approved drugs safe and effective for older adults? Here's what to know about new weight loss drugs
New Oral Weight Loss Drugs: Where Are We and What's Next? - Medscape
2024年6月5日 · Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with...
16 New Weight Loss Drugs - GoodRx
2024年10月1日 · Several new weight-loss drugs are making waves in clinical trials. This includes pills such as oral semaglutide, orforglipron, and amycretin. The same goes for injectable medications, such as retatrutide, CagriSema (cagrilintide and semaglutide), and MariTide (maridebart cafraglutide).
The Race for the Next Ozempic - WIRED
2024年7月24日 · This new drug, semaglutide, was first approved for diabetes in 2017 under the brand name Ozempic and then in 2021 for weight loss as Wegovy. In trials of the drug, participants who received...
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
2023年11月8日 · Eli Lilly & Co., maker of Zepbound, says it shows greater weight loss at a lower list price than Wegovy. The Lilly drug will be available in the U.S. by the end of the year. A version of the...
GLP-1 pills are coming, and they could revolutionize weight-loss …
2024年9月17日 · New pill versions are in trials now. Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
2023年11月8日 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
2023年11月8日 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs. The drug,...
Weight loss drug Zepbound is now available, Eli Lilly says
2023年12月6日 · Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by the...